FilingSEC EDGAR8-K
Arcturus Announces Positive ARCT-810 Phase 2 Interim Results and Introduces LUNAR 2.0 Platform
· SEC accepted
StagePhase 2
Filing content
Arcturus announced positive interim Phase 2 results for ARCT-810, introduced its LUNAR 2.0 mRNA delivery platform, and announced the acquisition of myNEO.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…